Exchange Traded Concepts’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Exchange Traded Concepts's NVO Position: Q3 2026 in Review
Exchange Traded Concepts increased its Novo Nordisk (NVO) stake by 16% in Q3 2026, buying an estimated $1.09M and bringing the position to 169,950 shares worth $6.44M. The position accounts for 0.03% of the portfolio, ranked #455.
Exchange Traded Concepts first reported a position in NVO in Q2 2024 and has held it in 10 quarters since. The position peaked at $8.73M in Q4 2025. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Exchange Traded Concepts held 169,950 shares of Novo Nordisk worth $6.44M as of Q3 2026.
- Exchange Traded Concepts bought 23,716 Novo Nordisk shares in Q3 2026, an estimated $1.09M.
- Novo Nordisk made up 0.03% of Exchange Traded Concepts's portfolio in Q3 2026, its #455 holding.
- Exchange Traded Concepts first reported a position in Novo Nordisk in Q2 2024 and has held it in 10 quarters since.
- Exchange Traded Concepts's Novo Nordisk position peaked at $8.73M in Q4 2025.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.